Adaptin
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='2vgl' size='350' side='right' caption='Structure of Adaptin core: AP-α (grey), AP-β (light green), AP-μ (green), AP-σ (olive green) complex with inositole hexakisphosphate (PDB entry [[2vgl]])' scene=''> | + | <StructureSection load='2vgl' size='350' side='right' caption='Structure of Adaptin core: AP-α-2 (grey), AP-β-1 (light green), AP-μ-1 (green), AP-σ-1 (olive green) complex with inositole hexakisphosphate (PDB entry [[2vgl]])' scene=''> |
'''Adaptin''' (AP) are proteins which mediate the formation of vescicles by clathrin-coated pits. The AP complex is a hetertetramer composed of 2 large AP: AP-α or AP-γ and AP-β, a medium-size AP: AP-μ and small AP: AP-σ. AP complexes connect proteins and lipids to clathrin budding sites. There are different AP complexes in mammals. | '''Adaptin''' (AP) are proteins which mediate the formation of vescicles by clathrin-coated pits. The AP complex is a hetertetramer composed of 2 large AP: AP-α or AP-γ and AP-β, a medium-size AP: AP-μ and small AP: AP-σ. AP complexes connect proteins and lipids to clathrin budding sites. There are different AP complexes in mammals. | ||
| Line 6: | Line 6: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | '''AP-α''' | + | '''AP-α-2''' |
[[1b9x]], [[1qts]] – mAP appendage domain – mouse<br /> | [[1b9x]], [[1qts]] – mAP appendage domain – mouse<br /> | ||
| Line 18: | Line 18: | ||
'''AP-β''' | '''AP-β''' | ||
| - | [[1e42]] | + | [[1e42]] – hAP-1 appendage domain - human<br /> |
| - | [[2g30]] – hAP appendage domain + ARH peptide<br /> | + | [[2g30]] – hAP-1 appendage domain + ARH peptide<br /> |
| - | [[ | + | [[3h1z]] – hAP-1 appendage domain + PTDINSPKI-γ peptide<br /> |
| - | [[ | + | [[3hs9]] – hAP-1 appendage domain + intersectin peptide<br /> |
| - | [[ | + | [[2iv9]] – hAP-2 appendage domain + eps15 peptide<br /> |
| - | [[ | + | [[2iv8]] – hAP-2 appendage domain + B-arrestin peptide<br /> |
'''AP-γ''' | '''AP-γ''' | ||
| - | [[1iu1 | + | [[1iu1]] – hAP-1 ear domain<br /> |
| - | [[ | + | [[1gyu]], [[2a7b]] – mAP-1 appendage domain <br /> |
| - | [[ | + | [[1gyv]], [[1gyw]], [[3zy7]] – mAP-1 appendage domain (mutant)<br /> |
| - | [[ | + | [[2e9g]], [[4bcx]] – hAP-2 ear domain<br /> |
| - | [[ | + | [[2ymt]] – hAP-2 ear domain + peptide<br /> |
| + | [[3zhf]] – hAP-2 ear domain + large envelope protein peptide<br /> | ||
| - | '''AP-δ''' | + | '''AP-δ-1''' |
| - | [[4afi]] – hAP/vesicle-associated membrane protein 7<br /> | + | [[4afi]] – hAP-1/vesicle-associated membrane protein 7<br /> |
'''AP-μ''' | '''AP-μ''' | ||
| - | [[ | + | [[3h85]] – rAP-1 appendage domain + PTDINSPKIγ peptide<br /> |
| - | [[ | + | [[4emz]], [[4en2]] – mAP-1 sorting motif recognition domain + nef + MHC-I<br /> |
| - | [[ | + | [[1bw8]], [[1i31]] – rAP-2 + EGFR peptide<br /> |
| - | [[ | + | [[1bxx]] – rAP-2 + TGN38 peptide<br /> |
| - | [[ | + | [[1hes]] – rAP-2 + selectin peptide<br /> |
| - | [[ | + | [[2bp5]] – rAP-2 + purinoceptor peptide<br /> |
| - | [[ | + | [[2pr9]] – rAP-2 + GABA receptor peptide<br /> |
'''AP-α + AP-β + AP-μ + AP-σ''' | '''AP-α + AP-β + AP-μ + AP-σ''' | ||
| - | [[2vgl]] – rAPα + APβ + APμ + APσ <br /> | + | [[2vgl]] – rAPα-2 + APβ-1 + APμ-1 + APσ-1 <br /> |
| - | [[2jkr]], [[2jkt]] – mAPα + APβ + APμ + APσ + CD4 peptide<br /> | + | [[2jkr]], [[2jkt]] – mAPα-2 + APβ-1 + APμ-1 + APσ-1 + CD4 peptide<br /> |
| - | [[2xa7]] – rAPα + APβ + APμ + APσ + cargo peptide<br /> | + | [[2xa7]] – rAPα-2 + APβ + APμ + APσ + cargo peptide<br /> |
'''AP-γ + AP-β + AP-μ + AP-σ''' | '''AP-γ + AP-β + AP-μ + AP-σ''' | ||
| - | [[1w63]] – mAPγ + APβ + APμ + APσ <br /> | + | [[1w63]] – mAPγ-1 + APβ-1 + APμ-1 + APσ-1A <br /> |
| - | [[4hmy]] – mAPγ + APβ + APμ + APσ + ADP-ribosylation factor<br /> | + | [[4hmy]] – mAPγ-1 + APβ-1 + APμ-1 + APσ-3 + ADP-ribosylation factor<br /> |
| + | |||
| + | [[Category:Topic Page]] | ||
Revision as of 06:40, 30 June 2014
| |||||||||||
